Integra Lifesciences Holdings (IART) Other Non-Current Assets (2009 - 2026)

Integra Lifesciences Holdings has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $31.6 million for Q2 2026.

• In Q2 2026, Other Non-Current Assets fell 31.68% year-over-year to $31.6 million; the TTM figure through Jun 2026 stood at $31.6 million (down 31.68% YoY), while the FY2025 annual figure was $37.9 million, down 43.05% from the prior year.
• Other Non-Current Assets came in at $31.6 million for Q2 2026 at Integra Lifesciences Holdings, down from $35.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $77.9 million in Q3 2023 to a low of $29.5 million in Q1 2022.
• Average Other Non-Current Assets over 5 years is $54.3 million, with a median of $55.1 million recorded in 2023.
• Year-over-year, Other Non-Current Assets jumped 247.87% in 2022 and sank 43.05% in 2025.
• Over 5 years, Other Non-Current Assets stood at $57.2 million in 2022, then advanced by 1.76% to $58.2 million in 2023, then gained by 14.3% to $66.5 million in 2024, then slumped by 43.05% to $37.9 million in 2025, then slipped by 16.6% to $31.6 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $31.6 million in Q2 2026, $35.0 million in Q1 2026, and $37.9 million in Q4 2025.